Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BICC-C: Irinotecan Regimens with Celecoxib and Bevacizumab in mCRC
NCT00101686Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2003
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of celecoxib oral solution in metastatic colorectal cancer (mCRC), sponsored by Pfizer. Started Feb 2003; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00101686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101686.